ACCC's Drug Bulletin on Hold Until 2009
FDA Approves Treanda to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
CMS Releases Final 2009 Hospital Outpatient Department Rule, ASP +4 Percent
CMS Releases Final 2009 Changes to Payment Policies and Rates Under Medicare Physician Fee Schedule
CMS Releases Guidance on Use of Drug Compendia
FDA Grants Full Approval to Ontak for Cutaneous T-Cell Lymphoma
CMS Announces RAC Program Details
FDA Approves Lilly's Alimta for New Indication
CMS to Issue Guidance on Use of Recognized Compendia, But Gives No Firm Date
ACCC's Oncology Economics Conference Scores Great Success
ACCC Submits Comments on 2009 Proposed HOPPS Rule to CMS
Vidaza Gets FDA Approval to Change Prescribing Information
ACCC Comments on 2009 Physician Fee Schedule and Other Revisions to Part B
FDA Approves Nplate for Long-Term Treatment of Adult Chronic ITP
E&M Services Guide Available from CMS
Ortho Biotech Announces Nationwide Voluntary Recall of Procrit Lot Number P114942A
No Medicare Expansion of Colorectal Cancer Screening with PreGen-Plus
FDA Announces Proposed Label Revisions for ESAs
Calculating Drug Pricing
This easy–to–use spreadsheet can help your hospital analyze weighted average drug costs by payer in the ambulatory outpatient setting. Just follow the instructions, and weighted payments will be automatically calculated.
Click here to view or download the tool.
- OPEN provides needed education in critical areas that are essential for clinical and operational success.
- OPEN members receive the latest regulatory and legislative updates that apply to cancer delivery and the cancer program pharmacy.
- OPEN serves to increase understanding about the payment process, including Ambulatory Payment Classifications (APCs), Average Sales Price (ASP), and facility fees.
- OPEN members receive practical tools for assessing the bottom line and gain insight into drug purchasing.
- OPEN aids in communicating with your peers in other hospital pharmacy settings.
